SynthesisPloS one2025

Comparative efficacy and safety of dupilumab versus newly approved biologics and JAKi in pediatric atopic dermatitis: A systematic review and network meta-analysis.

Qiwei Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.